LAPIMUN MIX
Live vaccine against Myxomatosis
Composition
One dose of vaccine contains virus of Myxomatosis, strain MAV/RK – 13/20 ≥ 104,0 EID50.
Pharmaceutical form
Freeze-dried tablet, or freeze-dried tablet and solvent.
Immunological properties
Induces postvaccinal protection in healthy rabbits on 4-9th day after vaccination that lasts for 8-10 months.
Target species
Rabbits.
Indications
Preventative immunization of rabbits against Myxomatosis.
Interaction with other preparations
The vaccine can be used simultaneously with the vaccine against Hemorrhagic Disease LAPIMUN GEM which is administered at the opposite side. Dehelmintisation of rabbits is to be performed 2 weeks prior to or 2 weeks after vaccination
Special precautions (during gestation period)
No contraindications.
Route of administration and dosage
Just before use vaccine should be dissolved in Solvent for Live Vaccines or in sterile saline solution at the rate of 1.0 ml per one dose.
|
Animal types and status of farm |
Age groups |
Dosage |
Methods |
|
Rabbits in non-endemic areas |
Single dose, at the age of 10 weeks |
1.0 ml |
Subcutaneously, behind the shoulder blade |
|
Rabbits in endemic areas |
First dose at the age of 4 weeks with revaccination at the age of 4 months |
||
|
Adult rabbits |
The last 7 days before mating |
In the future the vaccination of animals is carried out every 8 months.
Withdrawal period
0 days.
Self life
24 months. Vaccine should be used within 3 hours after dissolving.
Storage conditions
Store vaccine in dry, dark places, out of the reach of children, at +2 to +8° С. Do not freeze!